052-5633265
הפרעת קשב?!
ילדות דיגיטלית

|

|

gmail
052-5633265
ילדות דיגיטלית
הפרעת קשב?!
ילדות דיגיטלית

פרק 7: איך מחליטים שתרופות פסיכיאטריות מסוימות הן טיפול ראוי? התשתית הרעיונית לדיון בלגיטימיות של התרופות להפרעת קשב

רשימת מקורות

  1. Barkley RA. This is how you treat ADHD based off science, Dr Russell Barkley part of 2012 Burnett Lecture. keynote lecture at the 2012 Burnett Seminar for Academic Achievement, last retrieved on August 24, 2021, from:  https://www.youtube.com/watch?v=_tpB-B8BXk0; 2012.
  2. National Institute of Mental Health. NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: November 16-18, 1998, William H. Natcher Conference Center, National Institutes of Health, Bethesda, Maryland. National Institutes of Health, Continuing Medical Education; 1998.
  3. American Academy of Pediatrics. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2011;128(5):1007. doi:10.1542/peds.2011-2654
  4. Bolea-Alamañac B, Nutt DJ, Adamou M, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2014/03/01 2014;28(3):179-203. doi:10.1177/0269881113519509
  5. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE Guideline [NG87]. Last retrieved on August 20, 2021 from: https://www.nice.org.uk/guidance/NG87; 2018.
  6. The American Academy of Pediatrics Parenting Website. Common ADHD Medications & Treatments for Children. Healthy Children.org by the American Academy of Pediatrics. Last retrieved on November 16, 2021, from  https://www.healthychildren.org/English/health-issues/conditions/adhd/Pages/Determining-ADHD-Medication-Treatments.aspx; 2019.
  7. Piper BJ, Ogden CL, Simoyan OM, et al. Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016. PloS one. 2018;13(11):e0206100.
  8. Raman SR, Man KKC, Bahmanyar S, et al. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry. 2018;5(10):824-835.
  9. Burcu M, Zito JM, Metcalfe L, Underwood H, Safer DJ. Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014. JAMA Psychiatry. 2016;73(9):992-993. doi:10.1001/jamapsychiatry.2016.1182
  10. נובורטיס ישראל. עלון לצרכן לפי תקנות הרוקחים של תרופת הריטלין. נובורטיס פארמה, בזל, שווייץ. עלון זה נבדק ואושר על-ידי משרד הבריאות בפברואר 2017.; 2017.
  11. CIBA. The Many Faces of Ritalin. Bonkers Institute. Last retrieved on March 3, 2024 from: http://www.bonkersinstitute.org/medshow/kidritface.html; 1979.
  12. Danielson ML, Bitsko RH, Ghandour RM, Holbrook JR, Kogan MD, Blumberg SJ. Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016. Journal of Clinical Child & Adolescent Psychology. 2018/03/04 2018;47(2):199-212. doi:10.1080/15374416.2017.1417860
  13. Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry. 2014;53(1):34-46.
  14. Visser SN, Danielson ML, Wolraich ML, et al. Vital signs: national and state-specific patterns of attention deficit/hyperactivity disorder treatment among insured children aged 2–5 years—United States, 2008–2014. Morbidity and Mortality Weekly Report. 2016;65(17):443-450.
  15. McCabe SE, Schulenberg JE, Wilens TE, Schepis TS, McCabe VV, Veliz PT. Prescription Stimulant Medical and Nonmedical Use Among US Secondary School Students, 2005 to 2020. JAMA Network Open. 2023;6(4):e238707-e238707. doi:10.1001/jamanetworkopen.2023.8707
  16. Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D. Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010. Pediatrics. 2012;130(1):23. doi:10.1542/peds.2011-2879
  17. Qato DM, Alexander GC, Guadamuz JS, Lindau ST. Prescription Medication Use Among Children and Adolescents in the United States. Pediatrics. 2018;142(3):e20181042. doi:10.1542/peds.2018-1042
  18. Cohen E, Hall M, Lopert R, et al. High-Expenditure Pharmaceutical Use Among Children in Medicaid. Pediatrics. 2017;140(3):e20171095. doi:10.1542/peds.2017-1095
  19. Smith M. Hyperactive Around the World? The History of ADHD in Global Perspective. Social History of Medicine. 2017;30(4):767-787. doi:10.1093/shm/hkw127
  20. Elliott C. Better than well: American medicine meets the American dream. WW Norton & Company; 2004.
  21. Ophir Y. Evidence that the Diagnosis of ADHD Does Not Reflect a Chronic Bio-Medical Disease. Ethical Human Psychology and Psychiatry. 2022;23-2
  22. Brikell I, Yao H, Li L, et al. ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. The Lancet Psychiatry. 2024;11(1):16-26.
  23. Hoshen MB, Benis A, Keyes KM, Zoëga H. Stimulant use for ADHD and relative age in class among children in Israel. Pharmacoepidemiology and drug safety. 2016;25(6):652-660.
  24. International Narcotics Control Board. Psychotropic Substances Statistics for 2018 Assessments of Annual Medical and Scientific Requirements. United Nations –  Vienna: https://www.incb.org/documents/Psychotropics/technical-publications/2019/PSY_Technical_Publication_2019.pdf; 2019.
  25. International Narcotics Control Board. Psychotropic Substances Statistics for 2019 Assessments of Annual Medical and Scientific Requirements for 2021. United Nations –  Vienna: https://www.incb.org/documents/Psychotropics/technical-publications/2020/20-06957_Psychotropics_2020_ebook.pdf; 2020.
  26. Drug Enforcement Administration (DEA). Controlled Substance Schedules. The U.S. Department of Justice. Last retrieved on September 5, 2023 from: https://www.deadiversion.usdoj.gov/schedules/; 2023.
  27. APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Association; 2013.
  28. APA. Diagnostic and Statistical Manual of  Mental Disorders, 5th edition, Text Revision (DSM-5-TR). American Psychiatric Association.  Washington, DC; 2022.
  29. Molina BSG, Hinshaw SP, Swanson JM, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child & Adolescent Psychiatry. 2009;48(5):484-500.
  30. First MB, Yousif LH, Clarke DE, Wang PS, Gogtay N, Appelbaum PS. DSM‐5‐TR: Overview of what’s new and what’s changed. World Psychiatry. 2022;21(2):218.
  31. Torres-Acosta N, O’Keefe James H, O’Keefe Caroline L, Lavie Carl J. Cardiovascular Effects of ADHD Therapies. Journal of the American College of Cardiology. 2020/08/18 2020;76(7):858-866. doi:10.1016/j.jacc.2020.05.081
  32. Negrao BL, Crafford D, Viljoen M. The effect of sympathomimetic medication on cardiovascular functioning of children with attention-deficit/hyperactivity disorder: cardiovascular topic. Cardiovascular journal of Africa. 2009;20(5):296-299.
  33. Rasmussen N. Medical Science and the Military: The Allies' Use of Amphetamine during World War II. The Journal of Interdisciplinary History. 2011;42(2):205-233. doi:10.1162/JINH_a_00212
  34. אופיר י. הסמים שהמחבלים לקחו העניקו להם חוסר פחד – את האכזריות הם הביאו מהבית. מקור ראשון. נדלה לאחרונה בתאריך 27.5.2024 מאתר: https://www.makorrishon.co.il/opinion/694281/; 2023.
  35. Arnsten AFT. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology. 2006;31(11):2376-2383.
  36. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychological bulletin. 1997;121(1):65.
  37. Nigg JT. Is ADHD a disinhibitory disorder? Psychological bulletin. 2001;127(5):571.
  38. Eisenberg L. Commentary with a historical perspective by a child psychiatrist: when "ADHD" was the "brain-damaged child". 2007;(1044-5463 (Print))
  39. Freeman W, Watts JW. Prefrontal lobotomy: the surgical relief of mental pain. Bulletin of the New York Academy of Medicine. 1942;18(12):794.
  40. Terrier L-M, Lévêque M, Amelot A. Brain Lobotomy: A Historical and Moral Dilemma with No Alternative? World Neurosurgery. 2019/12/01/ 2019;132:211-218. doi:https://doi.org/10.1016/j.wneu.2019.08.254
  41. Freudenthal R, Moncrieff J. ‘A landmark in psychiatric progress’? The role of evidence in the rise and fall of insulin coma therapy. History of Psychiatry. 2022/03/01 2021;33(1):65-78. doi:10.1177/0957154X211062538
  42. דוידוביץ נ, קרנצלר י, מירון א. השימוש המוגבר במשככי כאבים נרקוטיים בישראל: תחילתה של מגפה? : מרכז טאוב לחקר המדיניות החברתית בישראל. נדלה לאחרונה בתאריך 30.6.2023 מאתר https://www.taubcenter.org.il/research/opioid-epidemic/; 2023.
  43. Netflix. Painkiller. Netflix, Inc. US.; 2023.
  44. Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC medicine. 2016;14(1):1-11.
  45. Belmaker RH, Lichtenberg P. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment. Springer; 2023.

 

בחזרה לעמוד הראשי של רשימת המקורות של הספר, לחצו כאן. 

להזמנת הרצאות ויצירת קשר

Created by Better Digital – Social & Marketing  All rights reserved©לוגו-better

כל הזכויות שמורות לד"ר יעקב אופיר 2019

גלילה לראש העמוד
דילוג לתוכן